Healthpeak Properties (NYSE:DOC) Updates FY 2024 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY 2024 earnings guidance on Friday. The company provided EPS guidance of 1.800-1.820 for the period, compared to the consensus EPS estimate of 1.800. The company issued revenue guidance of -.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $20.93 on Friday. Healthpeak Properties has a 52 week low of $16.01 and a 52 week high of $23.26. The company has a 50-day moving average price of $21.97 and a 200 day moving average price of $21.33. The company has a market cap of $14.64 billion, a P/E ratio of 44.53, a PEG ratio of 2.37 and a beta of 1.13. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). The business had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The firm’s quarterly revenue was up 25.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.45 earnings per share. Research analysts predict that Healthpeak Properties will post 1.8 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.73%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s dividend payout ratio (DPR) is 255.32%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on DOC shares. Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their price target for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Wells Fargo & Company reduced their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday. Scotiabank raised their price target on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research report on Monday, September 9th. Robert W. Baird lifted their price target on Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Finally, Mizuho dropped their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $22.93.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.